Pioneers precision neurotherapeutics that restore brain health by strengthening neural connections for neuropsychiatric and cognitive disorders.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Syndeio Biosciences is a synapse-focused biotechnology company pioneering a new class of therapies for neuropsychiatric and cognitive disorders by leveraging advanced synapse biology and pharmacology. The company develops precision neurotherapeutics that restore brain health by strengthening neural connections, using proprietary platforms and innovative mechanisms to address conditions such as depression, Alzheimer’s, and schizophrenia.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Syndeio Biosciences Management Team
Investors
AbbVie Ventures
Syndeio Biosciences Valuations & Financials
View real-time NPM data on Syndeio Biosciences stock including daily Syndeio Biosciences stock price estimates, valuation history, and historical share price information. Access Syndeio Biosciences financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Syndeio Biosciences pricing across six independent market signals. Looking for private company due diligence data sources on Syndeio Biosciences? Get in touch to learn more.
Similar Companies
like Syndeio Biosciences
Podium
Enterprise Software
Customer messaging platform enabling companies to connect at critical touch points.
Easun Reyrolle
Healthcare & Life Sciences
Delivers protection, control and automation systems for electrical networks.
IncubateHub
Digital innovation platform connecting corporations with startups and professionals to drive transformation through managed programs and hackathons.
Conduit
FinTech
Enables seamless international money movement using stablecoins and multi‑currency payment rails.
Nano-C
Produces nanostructured carbon chemicals to optimize hardware performance for green technologies.
MediSafe
Healthcare & Life Sciences
Delivers personalized medication reminders and adherence support to improve treatment routines.
METIS Intelligence
Hosts academic simulation conferences to train youth in international diplomacy and global policy analysis.
Infisical
Cybersecurity
Secure platform managing application secrets, certificates, SSH keys and configurations with automated controls for cloud and on-premises use.
HeraSoft
Develops enterprise software for workflow automation and digital transformation to improve operational efficiency.
FAQ
We have answers
Syndeio Biosciences stock does not trade on public stock exchanges. Syndeio Biosciences stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Syndeio Biosciences stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Syndeio Biosciences Stock does not trade on public stock exchanges. In order to sell Syndeio Biosciences shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Syndeio Biosciences does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Syndeio Biosciences share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for Syndeio Biosciences stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Syndeio Biosciences stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Syndeio Biosciences stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Syndeio Biosciences is a private company and has not had an IPO. There is currently no Syndeio Biosciences IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Syndeio Biosciences IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
